SAPAP1 Monoclonal Antibody

Part of the postsynaptic scaffold in neuronal cells.,similarity:Belongs to the SAPAP family.,subcellular location:Found in postsynaptic density of neuronal cells.,subunit:Interacts with guanylate kinase-like domain of DLG1, DLG2, DLG3, DLG4 and AIP1. Interacts with the PDZ domain of SHANK1, SHANK2 and SHANK3. Found in a complex with DLG4 and SHANK1, SHANK2 or SHANK3. Found in a complex with DLG4 and BEGAIN. Interacts with DYL2 and LRFN1.,tissue specificity:Expressed in brain.

The SAPAP1 Monoclonal Antibody is a cutting-edge biotechnological product designed to target and neutralize the SAPAP1 protein. This antibody is meticulously engineered using state-of-the-art techniques to ensure high specificity and affinity towards SAPAP1.

SAPAP1, also known as DLGAP1, plays a crucial role in synaptic plasticity and neuronal development. Dysregulation of SAPAP1 has been implicated in various neurological disorders, including autism spectrum disorders and obsessive-compulsive disorder.

Our SAPAP1 Monoclonal Antibody offers a reliable and effective solution for researchers and clinicians alike, aiming to investigate the role of SAPAP1 in disease pathogenesis and develop potential therapeutic interventions.

With its exceptional purity and consistency, this antibody guarantees reproducible results in a wide range of applications, including immunohistochemistry, western blotting, and flow cytometry. Its high specificity ensures minimal cross-reactivity, enabling accurate detection and quantification of SAPAP1 in various biological samples.

Furthermore, the SAPAP1 Monoclonal Antibody is produced under stringent quality control measures, ensuring batch-to-batch consistency and reliability. It is supplied in a convenient format, allowing for easy storage and handling.

Choose the SAPAP1 Monoclonal Antibody for your research and clinical needs, and unlock new insights into the intricate mechanisms underlying neurological disorders.